Q3 2025 Vext Science Inc Earnings Call Transcript
Key Points
- Revenue increased by 41% year-over-year, reaching $12.7 million, driven by contributions from Ohio dispensaries and resilience in Arizona.
- Vext Science Inc (VEXTF) generated positive operating cash flow for the fourth consecutive quarter, strengthening its business foundation.
- Ohio is identified as a growth engine with expanding adult-use sales and retail footprint, supported by strong customer retention and drive-through additions.
- Cultivation yields have improved significantly, with pilot programs delivering test yields nearly 50% above current averages, indicating potential for cost efficiency.
- Operating expenses decreased year-over-year and as a percentage of revenue, reflecting effective cost discipline and operational leverage.
- Arizona market remains challenging with excess supply and lower pricing, leading to a 12% sequential and 6% year-over-year decline in statewide sales.
- Adjusted EBITDA margin declined to 16.7% due to lower wholesale flower prices in Arizona, impacting margins and IFRS fair value of biological assets.
- The opening of the Fairfield store in Ohio has been delayed to early 2026 due to permitting issues, affecting short-term revenue and cash flow.
- Operating cash flow margin decreased to 9.9%, influenced by wholesale pricing movements and legacy income tax payments.
- The wholesale market in Arizona has not yet bottomed out, with ongoing pricing pressures and oversupply affecting profitability.
Thank you for standing by. This is the conference operator. Welcome to Vext Sciences third-quarter 2025 financial results conference call. As a reminder, all participants are in listen-only mode and the conference is being recorded. (Operator Instructions) I would now like to turn the conference over to Priam Shahrabordi. Please go ahead.
Thanks, operator. Good morning, everyone, and thank you for joining us today. Vext third-quarter 2025 financial results were released earlier this morning. The press release, financial statements, and MD&A are available on SEDAR+ as well as on the Vext website at vextscience.com.
We would like to remind listeners that portions of today's discussion includes forward-looking statements and that forward-looking statements are included in today's filings. There can be no assurance that these forward-looking statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances, or results contained therein will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
